Showing results (461-470 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|February 19, 2008
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancersJianbo Wang, Ryan Day, Yiyu Dong, et al.
Molecular Cancer Therapeutics|February 19, 2008
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerMin Li, Uddalak Bharadwaj, Rongxin Zhang, et al.
Molecular Cancer Therapeutics|February 19, 2008
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancerGiuseppe Filomeni, Paola Turella, Maria Luisa Dupuis, et al.
Molecular Cancer Therapeutics|February 19, 2008
Growth inhibition by STI571 in combination with radiation in human chronic myelogenous leukemia K562 cellsFlorence Huguet, Nicole Giocanti, Christophe Hennequin, et al.
Molecular Cancer Therapeutics|March 22, 2014
Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signalingYun Dai, Hongmei Jiao, Guigen Teng, et al.
Molecular Cancer Therapeutics|February 27, 2014
The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancerRajat Banerjee, Elizabeth A Van Tubergen, Christina S Scanlon, et al.
Molecular Cancer Therapeutics|March 11, 2014
Concordance of genomic alterations between primary and recurrent breast cancerFunda Meric-Bernstam, Garrett M Frampton, Jaime Ferrer-Lozano, et al.
Molecular Cancer Therapeutics|March 14, 2014
Nuclear translocation of Hand-1 acts as a molecular switch to regulate vascular radiosensitivity in medulloblastoma tumors: the protein uPAR is a cytoplasmic sequestration factor for Hand-1Swapna Asuthkar, Venkateswara Rao Gogineni, Jasti S Rao, et al.
Molecular Cancer Therapeutics|October 15, 2009
Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcomaChong-Feng Gao, Qian Xie, Yu-Wen Zhang, et al.
Molecular Cancer Therapeutics|February 1, 2017
MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung CancerShigeki Nanjo, Sachiko Arai, Wei Wang, et al.
Pageof 599